$HCTI 5 SEC Filings

Filed On	Filing
14 Feb 2022	Form 5: Rosa David A, Director Holds 20,000 Non-qualified Stock Option (right to buy) (exercise price $2.25, expires Aug 14, 2026)
14 Feb 2022	Form 5: Gallagher Brendan, Director Holds 20,000 Non-qualified Stock Option (right to buy) (exercise price $2.25, expires Aug 14, 2026)
14 Feb 2022	Form 5: Kumar Anand, Vice President, Sales Holds 67,000 Incentive Stock Option (right to buy) (exercise price $0.40, expires Jan 1, 2031)
14 Feb 2022	Form 5: Kannappan Lakshmanan, Director Holds 50,000 Non-qualified Stock Option (right to buy) (exercise price $0.40, expires Jan 1, 2031)
14 Feb 2022	Form 5: Leo John C, Director Holds 20,000 Non-qualified Stock Option (right to buy) (exercise price $2.25, expires Aug 14, 2026)
14 Feb 2022	Form 5: Gill James Michael, Vice President, Finance Holds 29,000 Incentive Stock Option (right to buy) (exercise price $0.40, expires Jan 1, 2031)
14 Feb 2022	Form 5: Prakash Vivek, Director Holds 50,000 Non-qualified Stock Option (right to buy) (exercise price $0.40, expires Jan 1, 2031)
14 Feb 2022	Form 5: Ramachandran Thyagarajan, Chief Financial Officer Holds 75,000 Incentive Stock Option (right to buy) (exercise price $0.40, expires Jan 1, 2031)
14 Feb 2022	Form 5: Venkatachari Suresh, Director Holds 150,000 Incentive Stock Option (right to buy) (exercise price $0.40, expires Jan 1, 2031)
14 Feb 2022	Form 5: Sudish Mogli, Chief Technology Officer Holds 83,000 Incentive Stock Option (right to buy) (exercise price $0.40, expires Jan 1, 2031)
14 Feb 2022	Form 5: Kizhakevilayil Shibu, Director Holds 50,000 Non-qualified Stock Option (right to buy) (exercise price $0.40, expires Jan 1, 2031)
14 Feb 2022	Form 5: Bjornstad April, Director Holds 20,000 Non-qualified Stock Option (right to buy) (exercise price $2.25, expires Aug 14, 2026)

Comments